Abstract:Previous studies have demonstrated that promyelocytic leukemia zinc finger protein (PLZF) promotes the expression of gluconeogenic genes and hepatic glucose output, which leads to hyperglycemia. However, the role played by PLZF in regulating lipid metabolism is not known. In this study, we aimed to examine the function of PLZF in regulating hepatic lipid and glucose homeostasis and the underlying mechanisms. The expression of PLZF was determined in different mouse models with regard to non-alcoholic fatty liver disease (NAFLD). In the next step, adenoviruses that express PLZF (Ad-PLZF) or PLZF-specific shRNA (Ad-shPLZF) were utilized to alter PLZF expression in mouse livers and in primary hepatocytes. For the phenotype of the fatty liver, histologic and biochemical analyses of hepatic triglyceride (TG), serum TG and cholesterol levels were carried out. The underlying molecular mechanism for the regulation of lipid metabolism by PLZF was further explored using luciferase reporter gene assay and ChIP analysis. The results demonstrated that PLZF expression was upregulated in livers derived from ob/ob, db/db and diet-induced obesity (DIO) mice. Liver PLZF-overexpressing C57BL/6J mice showed fatty liver phenotype, liver inflammation, impaired glucose tolerance and insulin sensitivity. On the other hand, hepatic PLZF knockdown in db/db and DIO mice alleviated hepatic steatosis. Of note, we found that PLZF activates SREBP-1c gene transcription through binding directly to the promoter fragment of this gene, which would induce a repressor-to-activator conversion depending on its interaction with SIRT1 in the role played by PLZF in the transcription process through deacetylation. Thus, PLZF is identified as an essential regulator of hepatic lipid and glucose metabolism, where the modulation of its liver expression could open up a therapeutic path for treating NAFLD.

Control of hepatic gluconeogenesis by the promyelocytic leukemia zinc finger protein.

Mouse Promyelocytic Leukemia Zinc Finger Protein (PLZF) Regulates Hepatic Lipid and Glucose Homeostasis Dependent on SIRT1

Regulation Of Glucose Homeostasis And Lipid Metabolism By Ppp1r3g-Mediated Hepatic Glycogenesis

SCP4 Promotes Gluconeogenesis through FoxO1/3a Dephosphorylation.

Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice

Hepatic ZBTB22 promotes hyperglycemia and insulin resistance via PEPCK1‐driven gluconeogenesis

KLF10 transcription factor regulates hepatic glucose metabolism in mice

PGC1α protects against hepatic steatosis and insulin resistance via enhancing IL10-mediated anti-inflammatory response.

PGC1 protects against hepatic steatosis and insulin resistance via enhancing IL10-mediated anti-inflammatory response

Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines

Metabolic Crosstalk: Molecular Links Between Glycogen and Lipid Metabolism in Obesity

Involvement of KLF11 in Hepatic Glucose Metabolism in Mice Via Suppressing of PEPCK-C Expression.

Regulation of hepatic lipogenesis by the zinc finger protein Zbtb20

The Zinc Transporter Slc39a5 Controls Glucose Sensing and Insulin Secretion in Pancreatic Β-Cells Via Sirt1- and Pgc-1α-mediated Regulation of Glut2

Glucose-induced and ChREBP: MLX-mediated lipogenic program promotes hepatocellular carcinoma development

Forkhead Box P1 (FOXP1) Transcription Factor Regulates Hepatic Glucose Homeostasis

Proline hydroxylation of CREB-regulated transcriptional coactivator 2 controls hepatic glucose metabolism

The Long Non-Coding RNA Gm10768 Activates Hepatic Gluconeogenesis by Sequestering Microrna-214 in Mice

TAZ inhibits glucocorticoid receptor and coordinates hepatic glucose homeostasis in normal physiological states

The transcriptional repressor Zfp125 modifies hepatic energy metabolism in response to fasting and insulin resistance

The KLF14 Transcription Factor Regulates Hepatic Gluconeogenesis in Mice